Literature DB >> 7611292

Spectrum of small mutations in the dystrophin coding region.

T W Prior1, C Bartolo, D K Pearl, A C Papp, P J Snyder, M S Sedra, A H Burghes, J R Mendell.   

Abstract

Duchenne and Becker muscular dystrophies (DMD and BMD) are caused by defects in the dystrophin gene. About two-thirds of the affected patients have large deletions or duplications, which occur in the 5' and central portion of the gene. The nondeletion/duplication cases are most likely the result of smaller mutations that cannot be identified by current diagnostic screening strategies. We screened approximately 80% of the dystrophin coding sequence for small mutations in 158 patients without deletions or duplications and identified 29 mutations. The study indicates that many of the DMD and the majority of the BMD small mutations lie in noncoding regions of the gene. All of the mutations identified were unique to single patients, and most of the mutations resulted in protein truncation. We did not find a clustering of small mutations similar to the deletion distribution but found > 40% of the small mutations 3' of exon 55. The extent of protein truncation caused by the 3' mutations did not determine the phenotype, since even the exon 76 nonsense mutation resulted in the severe DMD phenotype. Our study confirms that the dystrophin gene is subject to a high rate of mutation in CpG sequences. As a consequence of not finding any hotspots or prevalent small mutations, we conclude that it is presently not possible to perform direct carrier and prenatal diagnostics for many families without deletions or duplications.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7611292      PMCID: PMC1801231     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  64 in total

1.  Determination of the exon structure of the distal portion of the dystrophin gene by vectorette PCR.

Authors:  R G Roberts; A J Coffey; M Bobrow; D R Bentley
Journal:  Genomics       Date:  1992-08       Impact factor: 5.736

2.  Improved detection of mutations in the p53 gene in human tumors as single-stranded conformation polymorphs and double-stranded heteroduplex DNA.

Authors:  D Soto; S Sukumar
Journal:  PCR Methods Appl       Date:  1992-08

3.  An intact cysteine-rich domain is required for dystrophin function.

Authors:  R D Bies; C T Caskey; R Fenwick
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

4.  Identification of a 2 base pair nonsense mutation causing a cryptic splice site in a DMD patient.

Authors:  A V Winnard; Y Jia-Hsu; R A Gibbs; J R Mendell; A H Burghes
Journal:  Hum Mol Genet       Date:  1992-11       Impact factor: 6.150

5.  Somatic reversion/suppression in Duchenne muscular dystrophy (DMD): evidence supporting a frame-restoring mechanism in rare dystrophin-positive fibers.

Authors:  C J Klein; D D Coovert; D E Bulman; P N Ray; J R Mendell; A H Burghes
Journal:  Am J Hum Genet       Date:  1992-05       Impact factor: 11.025

6.  DXS997 localized to intron 48 of dystrophin.

Authors:  F A Saad; C Busque; L Vitiello; G A Danieli
Journal:  Hum Mol Genet       Date:  1993-12       Impact factor: 6.150

7.  Beta-globin nonsense mutation: deficient accumulation of mRNA occurs despite normal cytoplasmic stability.

Authors:  S J Baserga; E J Benz
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

8.  Nonsense-codon mutations of the ornithine aminotransferase gene with decreased levels of mutant mRNA in gyrate atrophy.

Authors:  Y Mashima; A Murakami; R G Weleber; N G Kennaway; L Clarke; T Shiono; G Inana
Journal:  Am J Hum Genet       Date:  1992-07       Impact factor: 11.025

9.  Point mutations and polymorphisms in the human dystrophin gene identified in genomic DNA sequences amplified by multiplex PCR.

Authors:  M W Kilimann; A Pizzuti; M Grompe; C T Caskey
Journal:  Hum Genet       Date:  1992-05       Impact factor: 4.132

10.  Evidence to implicate translation by ribosomes in the mechanism by which nonsense codons reduce the nuclear level of human triosephosphate isomerase mRNA.

Authors:  P Belgrader; J Cheng; L E Maquat
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-15       Impact factor: 11.205

View more
  18 in total

1.  Becker muscular dystrophy due to an inversion of exons 23 and 24 of the DMD gene.

Authors:  Kevin M Flanigan; Diane Dunn; C Aaron Larsen; Livija Medne; Carsten B Bönnemann; Robert B Weiss
Journal:  Muscle Nerve       Date:  2011-11       Impact factor: 3.217

2.  Dystrophin isoform induction in vivo by antisense-mediated alternative splicing.

Authors:  Sue Fletcher; Abbie M Adams; Russell D Johnsen; Kane Greer; Hong M Moulton; Steve D Wilton
Journal:  Mol Ther       Date:  2010-03-23       Impact factor: 11.454

3.  Evaluation of point mutations in dystrophin gene in Iranian Duchenne and Becker muscular dystrophy patients: introducing three novel variants.

Authors:  Maryam Haghshenas; Mohammad Taghi Akbari; Shohreh Zare Karizi; Faravareh Khordadpoor Deilamani; Shahriar Nafissi; Zivar Salehi
Journal:  J Genet       Date:  2016-06       Impact factor: 1.166

Review 4.  Experience and strategy for the molecular testing of Duchenne muscular dystrophy.

Authors:  Thomas W Prior; Scott J Bridgeman
Journal:  J Mol Diagn       Date:  2005-08       Impact factor: 5.568

5.  Aminoglycoside antibiotics restore dystrophin function to skeletal muscles of mdx mice.

Authors:  E R Barton-Davis; L Cordier; D I Shoturma; S E Leland; H L Sweeney
Journal:  J Clin Invest       Date:  1999-08       Impact factor: 14.808

6.  The clinical and molecular genetic approach to Duchenne and Becker muscular dystrophy: an updated protocol.

Authors:  A J van Essen; A L Kneppers; A H van der Hout; H Scheffer; I B Ginjaar; L P ten Kate; G J van Ommen; C H Buys; E Bakker
Journal:  J Med Genet       Date:  1997-10       Impact factor: 6.318

7.  Deletions, not duplications or small mutations, are the predominante new mutations in the dystrophin gene.

Authors:  Janusz G Zimowski; Magdalena Pawelec; Joanna K Purzycka; Walentyna Szirkowiec; Jacek Zaremba
Journal:  J Hum Genet       Date:  2017-07-06       Impact factor: 3.172

8.  In-frame dystrophin following exon 51-skipping improves muscle pathology and function in the exon 52-deficient mdx mouse.

Authors:  Yoshitsugu Aoki; Akinori Nakamura; Toshifumi Yokota; Takashi Saito; Hitoshi Okazawa; Tetsuya Nagata; Shin'ichi Takeda
Journal:  Mol Ther       Date:  2010-09-07       Impact factor: 11.454

9.  Microdystrophin ameliorates muscular dystrophy in the canine model of duchenne muscular dystrophy.

Authors:  Jin-Hong Shin; Xiufang Pan; Chady H Hakim; Hsiao T Yang; Yongping Yue; Keqing Zhang; Ronald L Terjung; Dongsheng Duan
Journal:  Mol Ther       Date:  2013-01-15       Impact factor: 11.454

10.  A novel splice site mutation in a Becker muscular dystrophy patient.

Authors:  C Bartolo; A C Papp; P J Snyder; M S Sedra; A H Burghes; C D Hall; J R Mendell; T W Prior
Journal:  J Med Genet       Date:  1996-04       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.